🚀 Trendline Breakout Brewing in a Fundamentally Strong Pharma Stock

This chart is showing a high-probability multi-signal setup where technical structure and fundamentals are aligning for a potential upside move. 📊 Technical Breakdown 1. Elliott Wave Perspective The stock appears to have completed a corrective Wave (ABC) structure. The recent sideways consolidation (boxed region) suggests Wave B exhaustion. Current price action hints at the beginning of Wave C upward, which typically carries strong momentum. 2. MACD Divergence (Hidden Strength) During the consolidation phase, price made lower lows, but momentum (MACD) likely formed higher lows. This indicates a bullish divergence, signaling that selling pressure is weakening and accumulation may be happening quietly. 3. AVWAP as Key Trigger Level Price is now testing a downward sloping AVWAP / trendline resistance zone (~₹980–₹1000). This level is critical: Sustained breakout above this zone = trend reversal confirmation It can act as a launchpad for the next impulsive move 📈 Price Structure Insight Long-term: Downtrend Short-term: Base formation + higher lows Current setup: Compression near resistance → breakout potential 💰 Fundamental Edge This isn’t just a technical play — fundamentals support the story: ✅ Strong ROCE indicates efficient capital usage ✅ Consistent profit growth over multiple quarters ✅ Sector tailwind (Pharma stability + demand visibility) ✅ Likely institutional accumulation during consolidation 🔥 What This Means If the stock: Breaks and sustains above ₹1000 zone With volume expansion 👉 It can trigger a fast move toward ₹1080–₹1150+ levels ⚠️ Risk Note Failure to break resistance may lead to continued range-bound movement Always watch for false breakouts (bull traps) near trendlines 🧠 Simple Summary Structure: Corrective phase ending Momentum: Bullish divergence Level: AVWAP breakout zone Fundamentals: Strong backbone 👉 This is the kind of setup where smart money enters before the crowd notices.